Meridian Wealth Management’s Axsome Therapeutics AXSM Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $2.3M | Buy |
22,021
+1,000
| +5% | +$104K | 0.1% | 183 |
|
|
2025
Q1 | $2.45M | Sell |
21,021
-150
| -0.7% | -$17.5K | 0.12% | 168 |
|
|
2024
Q4 | $1.79M | Buy |
21,171
+150
| +0.7% | +$12.7K | 0.08% | 202 |
|
|
2024
Q3 | $1.89M | Sell |
21,021
-35
| -0.2% | -$3.15K | 0.09% | 185 |
|
|
2024
Q2 | $1.7M | Buy |
+21,056
| New | +$1.7M | 0.2% | 88 |
|
|
2024
Q1 | – | Sell |
-20,498
| Closed | -$1.63M | – | 214 |
|
|
2023
Q4 | $1.63M | Buy |
20,498
+1,275
| +7% | +$101K | 0.1% | 189 |
|
|
2023
Q3 | $1.34M | Buy |
19,223
+250
| +1% | +$17.5K | 0.08% | 201 |
|
|
2023
Q2 | $1.36M | Buy |
18,973
+2,500
| +15% | +$180K | 0.11% | 160 |
|
|
2023
Q1 | $1.02M | Buy |
16,473
+1,525
| +10% | +$94.1K | 0.09% | 206 |
|
|
2022
Q4 | $1.15M | Buy |
14,948
+1,878
| +14% | +$145K | 0.11% | 173 |
|
|
2022
Q3 | $583K | Buy |
13,070
+5,140
| +65% | +$229K | 0.06% | 255 |
|
|
2022
Q2 | $304K | Buy |
+7,930
| New | +$304K | 0.02% | 436 |
|